Efficacy and safety of revocarin in patients with impaired micturition due to prostatic adenoma. An open non-comparative study: results of a multicenter trial
Pushkar', D.Iu.; Loran, O.B.; Petrov, S.B.; Kogan, M.I.; Zhuravlev, V.N.
Urologiia 2008(1): 23 25-6
2008
ISSN/ISBN: 1728-2985 PMID: 18649675 Document Number: 624714
Patients with impaired micturition caused by prostatic adenoma received revocarin for 12-weeks. After the treatment all the patients showed relief of clinical symptoms proved by subjective assessment of urination quality (IPSS and QoL) and objective data (uroflowmetry, ultrasonography). Allergic reactions or other serious side effects were not registered. Thus, a 12-week course of revocarin demonstrated good clinical efficacy and safety in patients with urination problems because of prostatic adenoma. Revocarin can be recommended as an alternative to an original drug omnik.
Document emailed within 1 workday
Related Documents
Vinarov, A.Z.; Aliaev, I.G.; Apolikhin, O.I.; Mazo, E.B.; Darenkov, S.P.; Demidko, I.L.; Lokshin, K.L.; Medvedev, A.A.; Permiakova, O.V.; Spivak, L.G.; Shkol'nikov, M.E. 2010: Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression Urologiia 6: 3-10Wechsel, H.W.; Zerbib, M.; Pagano, F.; Coptcoat, M.J. 1996: Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer European Urology 30(Suppl): 7
Pruthi, R.K.; Mathew, P.; Valentino, L.A.; Sumner, M.J.; Seremetis, S.; Hoots, W.K. 2007: Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial Thrombosis and Haemostasis 98(4): 726-732
Che, T.-t.; Wang, X.; Liu, Y.-y.; Tian, H.-m.; Yang, G.-y.; Xu, M.; Xiao, C.-q.; Zhu, L.ü-y.; Lü, X.-f.; Yu, H.-l.; Zhang, X.-x.; Ren, Y. 2011: The efficacy and safety of recombinant human insulin injection in the treatment of diabetic patients:a multicenter, randomized, controlled and open-labeled clinical trial Zhonghua Nei Ke Za Zhi 50(1): 23-26
Hammond, A.; Andus, T.; Gierend, M.; Ecker, K-Walter.; Scholmerich, J.; Herfarth, H. 2004: Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis Hepato-Gastroenterology 51(59): 1345-1349
Gavrilova, S.I.; Kolykhalov, I.V.; Fedorova, I.B.; Selezneva, N.D.; Kalyn, I.B.; Roshchina, I.F.; Odinak, M.M.; Emelin, A.Iu.; Kashin, A.V.; Gustov, A.V.; Antipenko, E.A.; Korshunova, I.A.; Davydova, T.A.; Messler, G. 2010: Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(1): 62-69
Rajna, P.ét.; Szíjártó, E. 2006: Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV) Ideggyogyaszati Szemle 59(9-10): 361-372
Voznesenskaia, T.G.; Fokina, N.M.; Iakhno, N.N. 2010: Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(5 Part 1): 17-26
Omvik, P.; Thaulow, E.; Herland, O.B.; Eide, I.; Midha, R.; Turner, R.R. 1993: A double-blind, long-term, comparative study on quality of life, safety, and efficacy during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study Journal of Cardiovascular Pharmacology 22 Suppl A: S13-S19
Benevolenskaia, L.I.; Toroptsova, N.V.; Nikitinskaia, O.A.; Sharapova, E.P.; Korotkova, T.A.; Rozhinskaia, L.Ia.; Marova, E.I.; Dzeranova, L.K.; Molitvoslovova, N.N.; Men'shikova, L.V.; Grudinina, O.V.; Lesniak, O.M.; Evstigneeva, L.P.; Smetnik, V.P.; Shestakova, I.G.; Kuznetsov, S.Iu. 2004: Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial Terapevticheskii Arkhiv 76(11): 88-93
Enzi, G. 1997: A multicenter open study of dexfenfluramine in Italy. the efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. the DIMOS Group Terapevticheskii Arkhiv 69(5): 71-75
Aliaev, I.G.; Vinarov, A.Z.; Demidko, I.L.; Spivak, L.G. 2013: The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia Urologiia 4: 32-36
Chamorro, C.; de Latorre, F.J.; Montero, A.; Sánchez-Izquierdo, J.A.; Jareño, A.; Moreno, J.A.; Gonzalez, E.; Barrios, M.; Carpintero, J.L.; Martín-Santos, F.; Otero, B.; Ginestal, R. 1996: Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial Critical Care Medicine 24(6): 932-939
Wiegratz, I.; Bassol, S.; Weisberg, E.; Mellinger, U.; Merz, M. 2014: Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study Reproductive Sciences 21(12): 1518-1525
Gallup, E.; Plott, T. 2005: A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans Journal of Drugs in Dermatology: Jdd 4(1): 29-34
Bednarz, B.ła.; Jaxa-Chamiec, T.; Maciejewski, P.ł; Szpajer, M.ł; Janik, K.; Gniot, J.; Kawka-Urbanek, T.; Drozdowska, D.; Gessek, J.; Laskowski, H. 2005: Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMi pilot trial Kardiologia Polska 62(5): 421-427
Yokota, S.; Imagawa, T.; Nishikomori, R.; Takada, H.; Abrams, K.; Lheritier, K.; Heike, T.; Hara, T. 2017: Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase IIi pivotal study in Japanese patients Clinical and Experimental Rheumatology 35 Suppl 108(6): 19-26
Dube, A.; Deb, A.K.; Das, C.; Padhye, D.; Bhalla, H.; Basu, I.; Bs, M.; Srivastava, P.; Agarwal, R.; Agrawal, R.P.; Singh, R.M.; Kurlekar, U.; Pawar, R.; Shahavi, V.; Srivastava, A. 2018: A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase IIi Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection Journal of the Association of Physicians of India 66(12): 47-50
McLaurin, V.L.; Dunson, B.A.; Dunson, T.R. 1991: A comparative study of 35 mcg and 50 mcg combined oral contraceptives: results from a multicenter clinical trial Contraception 44(5): 489-503
Dunson, T.R.; McLaurin, V.L.; Israngkura, B.; Leelapattana, B.; Mukherjee, R.; Perez-Palacios, G.; Saleh, A.A. 1993: A comparative study of two low-dose combined oral contraceptives: Results from a multicenter trial Contraception 48(2): 109-119